Company / Book Value per Share
Actinium Pharmaceuticals, Inc. Book Value per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.251
FY2025
5-year range
$0.251 / $4.195
FY2021-FY2025
Trend
-80.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has declined for 4 consecutive years, from $4.195 in FY2021 to $0.251 in FY2025.
Based on SEC 10-K filings.
$0.251 in FY2025 with a 3-year CAGR of -57.7%.
Declined from $2.589 to $0.251 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -57.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Actinium Pharmaceuticals, Inc.'s book value per share has declined for 4 consecutive years.
- 3-year CAGR of -57.7%, indicating a declining trend.
- In FY2025, book value per share decreased 80.9% year-over-year.
- Peak book value per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.251 | -80.9% |
| FY2024 | $1.316 | -49.2% |
| FY2023 | $2.589 | -22.0% |
| FY2022 | $3.321 | -20.8% |
| FY2021 | $4.195 | +4616.9% |
| FY2011 | $0.089 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026